AZN (AstraZeneca) Days Sales Outstanding : 78.00 (As of Jun. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Days Sales Outstanding?

AstraZeneca's average Accounts Receivable for the three months ended in Jun. 2024 was $11,060 Mil. AstraZeneca's Revenue for the three months ended in Jun. 2024 was $12,938 Mil. Hence, AstraZeneca's Days Sales Outstanding for the three months ended in Jun. 2024 was 78.00.

The historical rank and industry rank for AstraZeneca's Days Sales Outstanding or its related term are showing as below:

AZN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.29 Med: 51.23 Max: 78.67
Current: 78.67

During the past 13 years, AstraZeneca's highest Days Sales Outstanding was 78.67. The lowest was 45.29. And the median was 51.23.

AZN's Days Sales Outstanding is ranked worse than
57.79% of 969 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs AZN: 78.67

AstraZeneca's Days Sales Outstanding declined from Jun. 2023 (85.45) to Jun. 2024 (78.00).

AstraZeneca Days Sales Outstanding Historical Data

The historical data trend for AstraZeneca's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Days Sales Outstanding Chart

AstraZeneca Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

49.25

50.68

47.98

54.49

62.22

AstraZeneca Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															85.45	88.90	74.78	70.09	78.00

Competitive Comparison of AstraZeneca's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, AstraZeneca's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Days Sales Outstanding falls into.

AstraZeneca Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

AstraZeneca's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7212	+	8407)	/	2 )	/	45811	*	365
=	7809.5					/	45811	*	365
=	62.22

AstraZeneca's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (11072	+	11047)	/	2 )	/	12938	*	365 / 4
=	11059.5					/	12938	*	365 / 4
=	78.00

AstraZeneca (NAS:AZN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

AstraZeneca Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZN1:Mexico AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZNA:Austria AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.